Sign up for our daily briefing

Make your busy days simpler with Axios AM/PM. Catch up on what's new and why it matters in just 5 minutes.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Stay on top of the latest market trends

Subscribe to Axios Markets for the latest market trends and economic insights. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Sports news worthy of your time

Binge on the stats and stories that drive the sports world with Axios Sports. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Tech news worthy of your time

Get our smart take on technology from the Valley and D.C. with Axios Login. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Get the inside stories

Get an insider's guide to the new White House with Axios Sneak Peek. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Catch up on coronavirus stories and special reports, curated by Mike Allen everyday

Catch up on coronavirus stories and special reports, curated by Mike Allen everyday

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Denver news?

Get a daily digest of the most important stories affecting your hometown with Axios Denver

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Des Moines news?

Get a daily digest of the most important stories affecting your hometown with Axios Des Moines

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Twin Cities news?

Get a daily digest of the most important stories affecting your hometown with Axios Twin Cities

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Tampa Bay news?

Get a daily digest of the most important stories affecting your hometown with Axios Tampa Bay

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Charlotte news?

Get a daily digest of the most important stories affecting your hometown with Axios Charlotte

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Screengrab via Cambridge Analytica

House Intelligence Committee members are looking into whether Cambridge Analytica, a data analysis and targeting firm used by the Trump campaign, may have played a role in colluding with Russia, The Daily Beast reports. A committee spokesman said the firm has been asked to provide the committee with information that might help its investigation but clarified that "Cambridge is not under investigation, and there is no suggestion of any wrongdoing by the company."

The backdrop: Cambridge is backed by Robert Mercer, a wealthy, conservative hedge fund mogul who contributed significantly to Trump's presidential campaign. Mercer and his daughter Rebekah are also partial owners of Breitbart, the conservative website led by former White House advisor Steve Bannon. Some argue that a link between the Russians and the Trump presidential campaign could lie in the data operation, although there is no evidence of a correlation at present.

Trump campaign officials and Republican data operatives have argued that Cambridge exaggerated its role in Trump's digital campaign.

  • For months after the election Cambridge touted its role in using "psychographic" data analysis that could predict Americans' political leanings, but was forced to walk those claims back after campaign officials refuted them. Axios spoke with nearly one dozen Republican data and advertising executives, who said that the firm was mostly used to do fundraising work in June of 2016 and pivoted its role to data and polling analysis in August.
  • In an interview with Axios last week, Trump Advertising Director Brad Parscale said he hired Cambridge Analytica at the beginning of the campaign because he needed to ramp up staff to help execute advertising buys quickly. Parscale said that he initially turned down their offer because of cost, but eventually brought them on when they agreed to do the work for less money. On Sunday, Parscale told 60 minutes that he didn't think Cambridge's "psychographic" techniques worked.

Cambridge is also facing an inquiry from British data privacy regulators that want to understand its rolein influencing Brexit votes.

The lawsuit that could change the investigation: David Carroll, an associate professor at Parsons School of Design in New York, is hoping that a legal loophole will grant him access to the information about Cambridge's data operation that is being sought by US Intelligence officials, per The Guardian. Under UK law, Carroll has the ability to ask for his data back from the company, so he is now trying to raise money to sue Cambridge's UK parent company, SCL Group Ltd, to learn how Cambridge profiled millions of Americans.

Go deeper

6 hours ago - Health

Biden says it's "not the time to relax" after touring vaccination site

President Biden speaking after visiting a FEMA Covid-19 vaccination facility in Houston on Feb. 26. Photo: Mandel Ngan/AFP via Getty Images

President Biden said Friday that "it's not the time to relax" coronavirus mitigation efforts and warned that the number of cases and hospitalizations could rise again as new variants of the virus emerge.

Why it matters: Biden, who made the remarks after touring a vaccination site in Houston, echoed CDC director Rochelle Walensky, who said earlier on Friday that while the U.S. has seen a recent drop in cases and hospitalizations, "these declines follow the highest peak we have experienced in the pandemic."

Updated 6 hours ago - Politics & Policy

Coronavirus dashboard

Illustration: Annelise Capossela/Axios

  1. Health: Most COVID-19 survivors can weather risk of reinfection, study says — "Twindemic" averted as flu reports plummet amid coronavirus crisis
  2. Vaccine: FDA advisory panel endorses J&J COVID vaccine for emergency use — About 20% of U.S. adults have received first vaccine dose, White House says — New data reignites the debate over coronavirus vaccine strategy.
  3. Economy: What's really going on with the labor market.
  4. Local: All adult Minnesotans will likely be eligible for COVID-19 vaccine by summer — Another wealthy Florida community receives special access to COVID-19 vaccine.
  5. Sports: Poll weighs impact of athlete vaccination.

The week markets went wild

Illustration: Lazaro Gamio

The markets just closed out a manic week.

Why it matters: Outsized — and in some cases historic — moves were evident across the board.

You’ve caught up. Now what?

Sign up for Mike Allen’s daily Axios AM and PM newsletters to get smarter, faster on the news that matters.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!